IndraLab

Statements


USP4-C311A leads to the dephosphorylation of p38. 2 / 2
| 2

reach
"USP4 (C311A) mutation did not inhibit the TAK1 polyubiquitination, and phosphorylation of TAK1, = JNK1/2, and p38 in angiotensin treated myocytes."

reach
"In the same context, the overexpression of mutant USP4 C311A decreased the phosphorylation of AKT and p38 (Supplementary Figs."